In conjunction with iron therapy in the haematological improvement of anaemic patients with fibroids prior to surgery.
For this indication, competent medicine agencies globally authorize below treatments:
Subcutaneous
3.6 - 3.6 mg
From 3.6 To 3.6 mg once every 28 day(s)
One 3.6 mg depot of goserelin injected subcutaneously into the anterior abdominal wall, every 28 days.
For women who are anaemic as a result of uterine fibroids: goserelin 3.6 mg depot with supplementary iron may be administered for up to three months before surgery.